Global Acne Medication Market (2021 to 2030)

DUBLIN, November 25, 2021 /PRNewswire/ — The report “Acne Drugs Market by Therapeutic Class, Formulation, Type, Acne Type and Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2021-2030” has been added to’s offer.

Logo for research and markets

At an estimated value of more than USD 91.38 billion In 2020, the global acne medication market is predicted to flourish at a CAGR of 3.9% and valued at more than USD 14.26 billion for the forecast year 2021-2030.

Acne is the most common skin condition generally caused by changes in skin structures. It affects nearly millions of adolescents around the world. Therefore, there is a huge demand for both topical and oral acne medications. Topical medications include creams, gels, and ointments made up of retinoids, benzoyl peroxide, salicylic acid, and others. On the other hand, oral acne medications are relatively more effective when moderate to severe acne does not respond to topical agents.

Market dynamics and trends

Numerous factors such as changing hormone levels, rising teenage population and increasing adoption of skin care products are significantly driving the growth of the global acne medication market. In addition, an excessive production of oil from the sebaceous glands and an unsanitary lifestyle cause acne to appear, which has a positive effect on the market growth.

However, side effects such as skin irritation, dry skin and erythema or redness of the skin due to the use of acne medication are expected to hinder the growth of the market. On the contrary, increased R&D in skin care and high market potential in untapped emerging countries are expected to be opportunistic for market growth. Furthermore, the growing incidence and severity of acne is one of the major factors that will fuel the market size during the forecast period

Market segments and scope of the study:

The global acne medication market share has been segmented on the basis of therapeutic grade, formulation, type, acne type, distribution channel, and geography. Based on therapeutic class, the market is divided into retinoids, antibiotics, benzoyl peroxide, salicylic acid, and others. According to the formulation, the market is segmented into topical medication and oral medication. By type, the market is divided into prescription drugs and over-the-counter drugs.

Based on the type of acne, the market is divided into non-inflammatory acne and inflammatory acne. According to the distribution channel, it is categorized as retail stores, e-commerce, and pharmacies and drug stores. Geographic fragmentation and analysis of each segment includes regions consisting of: North America, Europe, Asia-Pacific and RoW.

Geographical Analysis

In terms of geography, North America had a large market share in 2019. This is attributed to the increase in the use of skin care products and increased awareness about natural acne medication has propelled the demand for acne medication in this region. However, Asia-Pacific is expected to grow rapidly with increasing market size due to factors such as an increase in health care spending and increased demand for acne medicines in developing countries in the region.

Competitive landscape

Maximum growth opportunities make the acne medication market highly competitive. Some of the key players in the market include Almirall SA., Bausch Health Companies Inc., Galderma SA, Mayne Pharma Group Limited, GlaxoSmithKline Plc (GSK), Mylan NV, Pfizer Inc., Johnson & Johnson, Sun Pharmaceutical Industries Limited, Teva Pharmaceutical Industries Ltd. and much more. In recent years, companies have adopted a number of development strategies. For example, in June 2020, Bausch Health Companies Inc. and Ortho Dermatologics, announced that ARAZLO (tazarotene) Lotion is commercially available to healthcare professionals in the US. ARAZLO is the tazarotene acne treatment drug available in lotion formulation.

Also in February 2020, Almirall, SA (ALM) announced the development of Seysara (sarecycline), the advanced tetracycline-derived oral antibiotic for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris. The product is expected to be filed with the National Medical Products Administration (NMPA) in 2023.

Main topics covered:

1 Introduction
1.1. Report description
1.2. Who should read this report
1.3. Main Market Segments
1.4. research method

2. Acne Medication Market – Summary
2.1. Market Snapshot, 2020 – 2030, Million USD

3. Market overview
3.1. Market definition and scope
3.2. Market dynamics

4. Covid-19 Analysis
4.1. Impact on market size
4.2. End-user trends and preferences, and budget and economic impact
4.3. Strategies of Key Players to Address the Impact of Covid-19 on the Market

5. Market Share Analysis
5.1. Market Share Analysis of Top Acne Medication Providers, 2020

6. Global Acne Medication Market, By Therapeutic Class
6.1. Overview
6.2. retinoids
6.3. antibiotics
6.4. Salicylic acid
6.5. Benzoyl peroxide
6.6. others

7. Global Acne Medication Market, By Formulation
7.1. Overview
7.2. Topical Medicines
7.3. Oral Medications

8. Global Acne Medication Market Segment By Type:
8.1. Overview
8.2. Prescription Drugs
8.3. Over-the-counter (OTC) medications

9. Global Acne Medication Market, by Types of Acne:
9.1. Overview
9.2. Inflammatory Acne
9.3. Non-inflammatory acne

10. Global Acne Medication Market, By Distribution Channel
10.1. Overview
10.2. Supermarkets
10.3. Pharmacies and drugstores
10.4. E-commerce

11. Global Acne Medication Market by Regions:
11.1. Overview
11.2. North America
11.3. Europe
11.4. Asia-Pacific
11.5. Rest of the world

12. Company Profiles
12.1. Almirall SA
12.2. Bausch Health Companies Inc.
12.3. Johnson & Johnson
12.4. GlaxoSmithKline plc
12.5. Galderma
12.6. Mayne Pharma Group Limited
12.7. Viatris Inc.
12.8. Sun Pharmaceutical Industries Limited
12.9. Pfizer Inc.
12.10. Teva Pharmaceutical Industries Ltd.

For more information on this report, visit

Media contact:

Research and markets
Laura Wood, senior manager

For EST business hours, call +1-917-300-0470
For US/CAN Toll Free Call +1-800-526-8630
For GMT office hours, please call +353-1-416-8900

US Fax: 646-607-1907
Fax (outside the US): +353-1-481-1716



View original content:—by-therapeutic-class-formulation-type-acne-type-distribution- channel-and-region-301432137.html

SOURCE Research and markets

Leave a Comment